Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome
Pathology International Oct 06, 2017
Fukushima H, et al. - This research explored the characteristics of neuroblastic tumors (NT) with the opsoclonus-myoclonus-ataxia syndrome (OMS). It was discovered that the interval between OMS onset and the detection and initial treatment of NT was typically longer in patients with neurological sequelae than those without neurological sequelae. Its early detection and treatment at the phase of a clear follicular formation with multiple follicular dendritic cells (FDCs) could present favorable neurological outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries